Published September 21, 2018 | Version v1
Journal article Open

The Classification, Comparison and Behavior of Coronary Stents: A Focused Review on Materials and Clinical Studies & Complications

  • 1. Department of Biomedical Engineering, Sheikhbahaee University, Isfahan, Iran

Description

Abstract

In the past two decades, cardiovascular disease has become one of the leading causes of death in the world. For treatment of these diseases, according to the patient’s conditions, methods such as drug therapy, balloon angioplasty, stent implantation, and bypass surgery are used. Stent implantation can be considered the most common way to treat these diseases. In this article, considering the special importance of stents, we examine them. We classify the stents based on their design and point out the effect of the design on some of the properties of the stents. Also, we introduce the different generations of stents and compare them. Finally, we will examine some of the features of the artery wall and the behavior of the stent in the arteries. And we talk about the bad effects the stents can have on the body.

Introduction

The main task of the circulatory system is to provide the materials needed by all the biological cells of the body and to dispose of waste from cellular metabolism. Circulatory system consists of the heart and blood vessels. The heart is a muscular pump that pumps blood into the body. Blood vessels are a network of tubes that carry blood throughout the body and provide oxygen, nutrients, water and hormones, therefore; the presence of any disorder in blood supply can cause serious problems.

In recent decades, due to the progress of the industry, the life style of many people around the world has changed, which hazarded the health of people and made cardiovascular disease the world’s leading cause of mortality. Cardiovascular diseases effect on function and structure of the heart and blood vessels. Coronary artery disease is one of the most common cardiovascular diseases, that it affects more than five million Americans each year.

The heart muscle requires a constant supply of oxygen and nutrients for the proper and healthy functioning of the heart; this is the responsibility of coronary arteries. In normal state, the arteries have a smooth, elastic inlay that allows blood to flow freely. Blood consists of fatty substances that are stick to the internal walls of the arteries. The onset of this disease is a gradual process that can begin before a person’s adolescence and at older ages can cause the formation of fat masses on the walls of the arteries and, consequently, damage to the walls of the blood vessels. Cells release a kind of white blood cells for repair, but the process itself over time makes the walls of the vessels more sticky; therefore, other substance such as proteins, calcium and inflammatory cells-that are suspended in bloodstream- stick to the walls of the vessels and combine with the fat, the product substance, called plaque. Over time, plaque continues to build upon the walls of the arteries. As the plaque expands, the arteries become narrow and hard. This process is called Atherosclerosis. This process is commonly known as hardening of the vein, because the builds up of plaque, makes the walls of the artery thicker and restricts blood flow through the area that is supplied by the artery, so; the heart can’t receive blood, oxygen and nutrients it needs.

There are various therapeutic options for treating coronary artery disease. The doctor’s recommended treatment depends on the symptoms of patient and degree of damage to his heart. Treatment options can include:

• Drugs

Blood diluents such as Aspirin, Beta blockers and etc. can prevent arterial occlusion.

• Balloon angioplasty

Coronary balloon angioplasty is a process used to open blocked heart arteries. This method, involve the temporary placement of a small balloon in the artery obstructing area and inflate it to help expand the arteries.

• Coronary stent implantation

About one third of patients who have been using balloon angioplasty to open their vascular obstruction have been restenosis within six months, therefore; in most people undergoing angioplasty, during a process similarly, a tool called a Stent is also placed in the blocked artery. The stent is usually inserted into the artery after expansion of the artery by inflating the balloon. A stent is a latticed, metal scaffold that keeps the artery open and stays there permanently. Stent also reduces the odds of heart attack.

• Bypass surgery

Another treatment for the narrowing of the arteries is Bypass surgery; this involves the graft of a blood vessel from the chest, leg, or forearm to the coronary artery to redirect the blood around the blockage area. As result of this surgery, blood will reach the heart.

Notes

Biomedical Research and Reviews (ISSN 2631-3944)

Files

BRR-2-107.pdf

Files (734.3 kB)

Name Size Download all
md5:18faa18cf0090c02977a0b612ea0ae8d
734.3 kB Preview Download

Additional details

References

  • Demir AG, Previtali B, Qiang Ge, Vedani M, Wu W, et al.Biodegradable magnesium coronary stents: material, designand fabrication. International Journal of Computer IntegratedManufacturing. 2014. 27(10):936-945.
  • Buta JY, Carmichael K, Leong SW, Collins MJ. Coronary arterystents: identification and evaluation. J Clin Pathol. 2005Aug;58(8):795-804.
  • Wykrzykowska JJ, Onuma Y, Serruys PW. Advances in stent drugdelivery: the future is in bioabsorbable stents. Expert Opin DrugDeliv. 2009 Feb;6(2):113-126.
  • Costa MA, Sabate M, Kay IP, de Feyter PJ, Kozuma K, et al. Threedimensional intravascular ultrasonic volumetric quantificationof stent recoil and neointimal formation of two new generationtubular stents. Am J Cardiol. 2000 Jan;85(2):135-139.
  • Tada T, Byrne RA, Simunovic I, King LA, Cassese S, et al. Risk ofstent thrombosis among bare-metal stents, first-generationdrug-eluting stents, and second-generation drug-eluting stents:results from a registry of 18,334 patients. JACC: CardiovascularInterventions. 2013 Dec;6(12):1267-1274.
  • Shirzadfar H, Vahid F, Kiafar F, Aledavood S. A focused review onmaterials and generations of coronary stents. Adv Tissue EngRegen Med Open Access. 2018 May;4(3):71-77.
  • Hirlekar R, Patel M, Jain S, Kadam V. Drug eluting coronary arterystents. Current drug delivery. 2010 Dec;7(5):421-427.
  • Serruys PW, Kay IP, Disco C, Deshpande NV, de Feyter PJ.Periprocedural quantitative coronary angiography after PalmazSchatz stent implantation predicts the restenosis rate at sixmonths: results of a meta-analysis of the BElgian NEtherlandsStent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT IIand MUSIC trials. Multicenter Ultrasound Stent In Coronaries. JAm Coll Cardiol. 1999 Oct;34(4):1067-1074.
  • Kereiakes DJ, Cox DA, Hermiller JB, Midei MG, Bachinsky WB, etal. Usefulness of a cobalt chromium coronary stent alloy. Am JCardiol. 2003 Aug;92(4):463-466.
  • Ooy T, Lee J, Park K. Effects of ethylene glycol-based graft, starshaped, and dendritic polymers on solubilization and controlledrelease of paclitaxel. J Control Release. 2003 Dec;93(2):121-127.
  • Teomim D, Fishbien I, Golomb G, Orloff L, Mayberg M, et al.Perivascular delivery of heparin for the reduction of smoothmuscle cell proliferation after endothelial injury. J ControlRelease. 1999 Jun 28;60(1):129-142.
  • Kavanagh CA, Rochev YA, Gallagher WM, Dawson KA, Keenan AK.Local drug delivery in restenosis injury: thermoresponsive copolymers as potential drug delivery systems. Pharmacol Ther.2004 Apr;102(1):1-15.
  • Grube E, Gerckens U, Müller R, Büllesfeld L. Drug eluting stents:initial experiences. Z Kardiol. 2002;91 Suppl 3:44-48.
  • Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, et al. Apolymer-based, paclitaxel-eluting stent in patients with coronaryartery disease. N Engl J Med. 2004 Jan;350(3):221-231.15.
  • Van der Hoeven BL, Pires NM, Warda HM, Oemrawsingh PV,van Vlijmen BJ, et al. Drug-eluting stents: results, promises andproblems. Int J Cardiol. 2005 Mar;99(1):9-17.
  • Tamburino C, Capodanno D. Evolution of stents: past, present andfuture Evolution of stents: past, present and future. Expert RevCardiovasc Ther. 2009;7(5):443-446.
  • Yan BP, Ajani AE, Waksman R. Drug-eluting stents for thetreatment of in-stent restenosis: A clinical review. CardiovascRevasc Med. 2005 Jan-Mar;6(1):38-43.
  • Akin I, Schneider H, Ince H, Kische S, Rehders TC. Second-andthird-generation drug-eluting coronary stents. Herz. 2011May;36(3):190-196.
  • Morice MC, Serruys PW, Sousa JE, Fajadet J, Hayashi BE, et al.A randomized comparison of a sirolimus-eluting stent with astandard stent for coronary revascularization. N Engl J Med. 2002Jun 6;346(23):1773-1780.
  • Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, et al. Analysisof 14 trials comparing sirolimus-eluting stents with bare-metalstents. N Engl J Med. 2007 Mar 356(10):1030-1039.
  • Myung JL, Tae-Jin Youn, Park JJ, Il-Young Oh, Chang-Hwan Yoon,et al. Comparison of 9-month angiographic outcomes of Resolutezotarolimus-eluting and everolimus-eluting stents in a real worldsetting of coronary intervention in Korea. BMC Cardiovasc Disord.2013;13(1):65.
  • Navarese EP, Kowalewski M, Kandzari D, Lansky A, Górny B, et al.First-generation versus second-generation drug-eluting stents incurrent clinical practice: updated evidence from a comprehensivemeta-analysis of randomised clinical trials comprising 31379patients. Open Heart. 2014;1(1):e000064.
  • Cutlip D, Abbott JD. Comparison of drug-eluting intracoronarystents. UpToDate;2015.
  • Ormiston JA, Serruys PW. Bioabsorbable coronary stents.Circulation: Cardiovascular Interventions. 2009;2(3):255-260.
  • Rodriguez-Granillo A, Rubilar B, Rodriguez-Granillo G, RodriguezAE. Advantages and disadvantages of biodegradable platforms indrug eluting stents. World J Cardiol. 2011 Mar;3(3):84-92.
  • Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, et al.Early and late coronary stent thrombosis of sirolimus-elutingand paclitaxel-eluting stents in routine clinical practice: datafrom a large two-institutional cohort study. Lancet. 2007 Feb24;369(9562):667-678.
  • Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, et al. Pathologyof drug-eluting stents in humans: delayed healing and latethrombotic risk. J Am Coll Cardiol. 2006 Jul 4;48(1):193-202.
  • Holzapfel GA, Sommer G, Auer M, Regitnig P, Ogden RW. Layerspecific 3D residual deformations of human aortas with nonatherosclerotic intimal thickening. Ann Biomed Eng. 2007Apr;35(4):530-545.
  • Sommer G, Gasser TC, Regitnig P, Auer M, Holzapfel GA. Dissectionproperties of the human aortic media: an experimental study. JBiomech Eng. 2008 Apr;130(2):021007.
  • Holzapfel GA, Sommer G, Gasser TC, Regitnig P. Patient-specificbiomechanical analysis of plaque rupture during balloonangioplasty using MRI and mechanical testing. in Proceedings ofthe Conference on Human Biomechanics 2006;2006.
  • Gasser T, Landuyt M, Sommer G, Auer M, Verdonck P, et al. A histologically based anisotropic model of the abdominal aortic aneurysm. J Biomech. 2006;39:S401.
  • Sommer G, Regitnig P, Költringer L, Holzapfel GA. Biaxialmechanical properties of intact and layer-dissected humancarotid arteries at physiological and supraphysiological loadings.Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H898-H912.
  • Rhodin JA. Architecture of the vessel wall. Handbook ofphysiology, the cardiovascular system. 1980;2:1-31.
  • Etave F, Finet G, Boivin M, Boyer JC, Rioufol G, et al., Mechanicalproperties of coronary stents determined by using finite elementanalysis. J Biomech. 2001 Aug;34(8):1065-1075.
  • Dumoulin C, Cochelin B. Mechanical behaviour modelling ofballoon-expandable stents. J Biomech. 2000;33(11):1461-1470.
  • Auricchio F, Di Loreto M, Sacco E. Finite-element analysis ofa stenotic artery revascularization through a stent insertion.Comput Methods Biomech Biomed Engin. 2001;4(3):249-263.
  • Tan LB, Webb DC, Kormi K, Al-Hassani ST. A method forinvestigating the mechanical properties of intracoronary stentsusing finite element numerical simulation. Int J Cardiol. 2001Mar;78(1):51-67.
  • Ganguly A, Bennett NR, Herfkens RJ, Coogan SM, Fahrig R. et al.In-vivo imaging of femoral artery Nitinol stents for deformationanalysis. J Vasc Interv Radiol. 2011 Feb;22(2):244-249.
  • Nuutinen JP, Clerc C, Tormala P. Theoretical and experimentalevaluation of the radial force of self-expanding braidedbioabsorbable stents. J Biomater Sci Polym Ed. 2003;14(7):677-687.
  • Grenacher L, Lubienski A, Dux M, Kauffmann GW, Richter GM, et al.Experimental functional analysis of self-expanding stents using anew developed ex vivo model. Invest Radiol. 2004;39(6):374-383.
  • Howell BA, Kim T, Cheer A, Dwyer H, Saloner D, et al. Computationalfluid dynamics within bifurcated abdominal aortic stent-grafts. JEndovasc Ther. 2007;14(2):138-143.
  • Nikolov HN, David MP, Stephen PL, Chris JDN, Vajid K, et al. MicroCT–compatible technique for measuring self-expanding stentforces. J Vasc Interv Radiol. 2010;21(4):562-570.
  • Dangas G, Kuepper F. Restenosis: repeat narrowing of acoronary artery: prevention and treatment. Circulation,2002;105(22):2586-2587.
  • Kuntz RE, Safian RD, Carrozza JP, Fishman RF, Mansour M, etal. The importance of acute luminal diameter in determiningrestenosis after coronary atherectomy or stenting. Circulation.1992;86(6):1827-1835.
  • Huckle WR, Drag MD, Acker WR, Powers M, McFall RC, et al.Effects of L-749,329, an ETA/ETB endothelin receptor antagonist,in a porcine coronary artery injury model of vascular restenosis.Circulation. 2001;103(14):1899-1905.
  • Almagor M. Keren A, Banai S. Increased C-reactive protein levelafter coronary stent implantation in patients with stable coronaryartery disease. American heart journal. 2003;145(2):248-253.
  • Norgaz T, Hobikoglu G, Serdar ZA, Aksu H, Alper AT, et al. Is therea link between nickel allergy and coronary stent restenosis?Tohoku J Exp Med. 2005;206(3):243-246.
  • Köster R, Vieluf D, Kiehn M, Sommerauer M, Kähler J, et al. Nickeland molybdenum contact allergies in patients with coronary instent restenosis. The Lancet. 2000;356(9245):1895-1897.
  • Saito T, Hokimoto S, Oshima S, Noda K, Kojyo Y, et al. Metal allergicreaction in chronic refractory in-stent restenosis. CardiovascRevasc Med. 2009;10(1):17-22.
  • Hillen U, Haude M, Erbel R, Goos M. Evaluation of metalallergies in patients with coronary stents. Contact dermatitis,2002;47(6):353-356.
  • Fukahara K, Minami K, Reiss N, Fassbender D, Koerfer R. Systemicallergic reaction to the percutaneous patent foramen ovaleoccluder. J Thorac Cardiovasc Surg. 2003 Jan;125(1):213-214.
  • Iijima R, Ikari Y, Amiya E, Tanimoto S, Nakazawa G, et al. Theimpact of metallic allergy on stent implantation: metal allergy andrecurrence of in-stent restenosis. Int J Cardiol. 2005;104(3):319-325.